Warning letter · FDA Warning Letters, Historical Archive

Rooted Apothecary LLC: FDA Warning Letter 585312 (Oct 10, 2019)

Agency action: Oct 10, 2019Record ID: fda_warning_-3a46fcd2cb858fac
View official source ↗

What happened

Original notice title

Rooted Apothecary LLC MARCS-CMS 585312, October 10, 2019

From the archived source record

FDA has determined that your “Teeth/TMJ – Essential Oil + CBD Infusion,” “Ears – Essential Oil + CBD Infusion,” “Hemp Capsules, 750 mg,” “Hemp Infused Body Butter,” and “Hemp Oil” products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. 355(a) and 331(d). Furthermore, these products are misbranded drugs under section 502(f)(1) of the FD&C Act, 21 U.S.C. 352(f)(1). In addition, the Federal Trade Commission has reviewed your website for potential violations of Sections 5(a) and 12 of the FTC Act, 15 U.S.C. §§ 45(a) and 52. As FDA stated in an announcement regarding a warning letter on July 23, 2019, “while we recognize the potential opportunities and significant interest in drug products containing cannabis and cannabis-derived compounds like CBD, protecting and promoting public health remains our top priority.” [2] The Agency continues to be concerned about the proliferation of products asserting to contain CBD that are marketed for therapeutic or medical uses without having been reviewed for safety and effectiveness by the FDA as is required by law and to protect the public health. There are many unanswered questions about the science, safety, effectiveness and quality of unapproved products containing CBD. Without this information, we are unable to ensure that these products will not cause harm to people who use them. The Agency is particularly concerned that you market unapproved new drugs for uses in infants and children. For example, infants and children may be at greater risk for adverse reactions associated with certain drug products due to differences in the ability of infants and children to absorb, metabolize, distribute, or excrete such drug products or their metabolites.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Historical warning letter; closeout not established by annual index
Source checked
Jul 16, 2026
Record revision
d53e127d02d8

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Teeth/TMJ – Essential Oil + CBD Infusion; Hemp Capsules, 750 mg; Hemp Infused Body Butter; Hemp Oil; CBD Capsules, 750 mg; CBD Body Butter; CBD Oil; Ears – Essential Oil + CBD Infusion; Hemp Capsules; 750 mg” and “ Hemp Oil” products as dietary supplements
Company
Rooted Apothecary LLC
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.